Mind the gap - Managing tuberculosis across the disease spectrum

Area of Science:

• Infectious Diseases
• Pulmonary Medicine
• Microbiology

Background:

• Tuberculosis (TB) management traditionally follows a binomial approach: 6-month multi-drug regimens for active disease and shorter regimens for latent infection.
• Clinicians often encounter patients with indeterminate TB, presenting features between active disease and latent infection, particularly with increased chest X-ray screening.
• Recognizing TB as a spectrum of disease is driving new diagnostic strategies for early detection.

Purpose of the Study:

• To address the need for optimized tuberculosis treatment strategies.
• To investigate the efficacy of different treatment durations across the TB disease spectrum.
• To inform clinical trial design for refining TB management protocols.

Main Methods:

• The study proposes a review of current TB management guidelines and clinical practices.
• It highlights the necessity for prospective clinical trials to evaluate treatment outcomes.
• Focus is placed on defining optimal treatment durations based on disease extent.

Main Results:

• The standard 6-month regimen for active TB was established for extensive disease forms.
• Evidence suggests shorter treatment durations may be sufficient for less extensive forms of TB.
• A significant gap exists in evidence-based treatment recommendations for indeterminate TB cases.

Conclusions:

• The current binomial approach to TB management may not be optimal for all patients.
• Clinical trials are essential to establish evidence-based, spectrum-specific TB treatment durations.
• Optimizing TB treatment duration can improve patient outcomes and resource utilization.